Evidence for involvement of a tumor suppressor gene on 1p in malignant peripheral nerve sheath tumors

Cancer Genetics and Cytogenetics

Volumn 143, Issue 2, 2003, Pages 120-124

  Van Roy, Nadine ^a   Van Gele, Mireille ^a   Vandesompele, Jo ^a   Messiaen, Ludwine ^a   Van Belle, Simon ^a   Sciot, Raf ^b   Mortéle, Koen ^a   Gyselinck, Jan ^c   Michiels, Erna ^c   Forsyth, Ramses ^a   Van Marck, Erik ^d   De Paepe, Anne ^a   Speleman, Frank ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Queen Paola Children's Hospital   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; CAUSE OF DEATH; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME MAP; CHROMOSOME STRUCTURE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIPLOIDY; DISEASE COURSE; ELECTRON MICROSCOPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUNCTION; GENE LOCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LABORATORY TEST; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NERVE SHEATH TUMOR; PERIPHERAL NERVE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RADIOGRAPHY; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

EID: 0037716672     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00853-1     Document Type: Article

References (38)

1. Enzinger F., Weiss S. Primitive neuroectodermal tumors and related lesions. Enzinger F., Weiss S. Soft tissue tumors. 3rd edition:1995;929-964 Mosby, St. Louis.
2. Mertens F., Dal Cin P., De Wever I., Fletcher C.D., Mandahl N., Mitelman F., Rosai J., Rydholm A., Sciot R., Tallini G., van Den Berghe H., Vanni R., Willen H. Cytogenetic characterization of peripheral nerve sheath tumours. a report of the CHAMP study group J Pathol. 190:2000;31-38.
3. Plaat B.E., Molenaar W.M., Mastik M.F., Hoekstra H.J., te Meerman G.J., van den Berg E. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors. sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas Int J Cancer. 83:1999;171-178.
4. Mertens F., Rydholm A., Bauer H.F., Limon J., Nedoszytko B., Szadowska A., Willen H., Heim S., Mitelman F., Mandahl N. Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer. 61:1995;793-798.
5. Lothe R.A., Karhu R., Mandahl N., Mertens F., Saeter G., Heim S., Borresen-Dale A.L., Kallioniemi O.P. Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res. 56:1996;4778-4781.
6. Mechtersheimer G., Otano-Joos M., Ohl S., Benner A., Lehnert T., Willeke F., Moller P., Otto H.F., Lichter P., Joos S. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer. 25:1999;362-369.
7. Forus A., Weghuis D.O., Smeets D., Fodstad O., Myklebost O., van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas. I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas Genes Chromosomes Cancer. 14:1995;8-14.
8. Schmidt H., Taubert H., Meye A., Wurl P., Bache M., Bartel F., Holzhausen H.J., Hinze R. Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Cancer Lett. 155:2000;181-190.
9. Schmidt H., Wurl P., Taubert H., Meye A., Bache M., Holzhausen H.J., Hinze R. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer. 25:1999;205-211.
10. Schmidt H., Taubert H., Wurl P., Bache M., Bartel F., Holzhausen H.J., Hinze R. Cytogenetic characterization of six malignant peripheral nerve sheath tumors. comparison of karyotyping and comparative genomic hybridization Cancer Genet Cytogenet. 128:2001;14-23.
11. Berner J.M., Sorlie T., Mertens F., Henriksen J., Saeter G., Mandahl N., Brogger A., Myklebost O., Lothe R.A. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors. studies of CDKN2A and other genes of the pRB pathway Genes Chromosomes Cancer. 26:1999;151-160.
12. Nielsen G.P., Stemmer-Rachamimov A.O., Ino Y., Moller M.B., Rosenberg A.E., Louis D.N. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol. 155:1999;1879-1884.
13. Kourea H.P., Orlow I., Scheithauer B.W., Cordon-Cardo C., Woodruff J.M. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol. 155:1999;1855-1860.
14. Kourea H.P., Cordon-Cardo C., Dudas M., Leung D., Woodruff J.M. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas. the emerging role of p27(kip) in malignant transformation of neurofibromas Am J Pathol. 155:1999;1885-1891.
15. Basu T.N., Gutmann D.H., Fletcher J.A., Glover T.W., Collins F.S., Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 356:1992;713-715.
16. DeClue J.E., Papageorge A.G., Fletcher J.A., Diehl S.R., Ratner N., Vass W.C., Lowy D.R. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell. 69:1992;265-273.
17. Legius E., Marchuk D.A., Collins F.S., Glover T.W. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet. 3:1993;122-126.
18. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein B. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
19. Menon A.G., Anderson K.M., Riccardi V.M., Chung R.Y., Whaley J.M., Yandell D.W., Farmer G.E., Freiman R.N., Lee J.K., Li F.P. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A. 87:1990;5435-5439.
20. Legius E., Dierick H., Wu R., Hall B.K., Marynen P., Cassiman J.J., Glover T.W. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer. 10:1994;250-255.
21. National Institutes of Health Consensus Development Conference. Conference statement: neurofibromatosis. Arch Neurol 1988;45:575-8.
22. Mortele K., Lemmerling M., Defreyne L., Speleman F., De Potter C., Van Belle S., Kunnen M. Ossified retroperitoneal malignant schwannoma with spinal leptomeningeal metastases. Neuroradiology. 40:1998;48-50.
23. Van Roy N., Laureys G., Cheng N.C., Willem P., Opdenakker G., Versteeg R., Speleman F. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer. 10:1994;103-114.
24. Buroker N., Bestwick R., Haight G., Magenis R.E., Litt M. A hypervariable repeated sequence on human chromosome 1p36. Hum Genet. 77:1987;175-181.
25. Cooke H.J., Hindley J. Cloning of human satellite III DNA. different components are on different chromosomes Nucleic Acids Res. 6:1979;3177-3197.
26. Van Roy N., Jauch A., Van Gele M., Laureys G., Versteeg R., De Paepe A., Cremer T., Speleman F. Comparative genomic hybridization analysis of human neuroblastomas. detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines Cancer Genet Cytogenet. 97:1997;135-142.
27. Schleiermacher G., Peter M., Michon J., Hugot J.P., Vielh P., Zucker J.M., Magdelenat H., Thomas G., Delattre O. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer. 10:1994;275-281.
28. Van Gele M., Kaghad M., Leonard J.H., Van Roy N., Naeyaert J.M., Geerts M.L., Van Belle S., Cocquyt V., Bridge J., Sciot R., De Wolf-Peeters C., De Paepe A., Caput D., Speleman F. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer. 82:2000;823-826.
29. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated February 2002. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
30. Jhanwar S.C., Chen Q., Li F.P., Brennan M.F., Woodruff J.M. Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet. 78:1994;138-144.
31. Schwab M., Praml C., Amler L.C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer. 16:1996;211-229.
32. White P.S., Thompson P.M., Seifried B.A., Sulman E.P., Jensen S.J., Guo C., Maris J.M., Hogarty M.D., Allen C., Biegel J.A., Matise T.C., Gregory S.G., Reynolds C.P., Brodeur G.M. Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol. 36:2001;37-41.
33. Bauer A., Savelyeva L., Claas A., Praml C., Berthold F., Schwab M. Smallest region of overlapping deletion in 1p36 in human neuroblastoma. a 1 Mbp cosmid and PAC contig Genes Chromosomes Cancer. 31:2001;228-239.
34. Ejeskar K., Sjoberg R.M., Abel F., Kogner P., Ambros P.F., Martinsson T. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. Med Pediatr Oncol. 36:2001;61-66.
35. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
36. Ichimiya S., Nimura Y., Kageyama H., Takada N., Sunahara M., Shishikura T., Nakamura Y., Sakiyama S., Seki N., Ohira M., Kaneko Y., McKeon F., Caput D., Nakagawara A. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene. 18:1999;1061-1066.
37. Takada N., Ozaki T., Ichimiya S., Todo S., Nakagawara A. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res. 59:1999;2810-2814.
38. Bown N., Cotterill S., Lastowska M., O'Neill S., Pearson A.D., Plantaz D., Meddeb M., Danglot G., Brinkschmidt C., Christiansen H., Laureys G., Speleman F. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 340:1999;1954-1961.